Solid-phase synthesis of sulfopeptides for evaluation of chemokine-receptor recognition. This research program will develop new chemical methods for preparing biologically active molecules that contain sulphate. These molecules have important functions in controlling blood clotting, hormone activity, immune responses, and AIDS or malarial infection. The new chemical methods will be used to study the interactions of two groups of proteins that control the movement of white blood cells in inflamma ....Solid-phase synthesis of sulfopeptides for evaluation of chemokine-receptor recognition. This research program will develop new chemical methods for preparing biologically active molecules that contain sulphate. These molecules have important functions in controlling blood clotting, hormone activity, immune responses, and AIDS or malarial infection. The new chemical methods will be used to study the interactions of two groups of proteins that control the movement of white blood cells in inflammatory responses. The research will provide insights into the biochemistry of inflammation and will contribute to the development of new therapies for diseases affecting young Australians (allergy, asthma, and viral infections) as well as the elderly (atherosclerosis and arthritis).Read moreRead less
Synthetic extracellular matrices for control of cellular reprogramming. This project aims to design materials that control the cellular environment for the fast, efficient, and reproducible production of reprogrammed cells in embryo-like architectures. Regenerative medicine has entered a new era, where reprogramming a patient’s cells is now possible for studying and treating disease. The expected outcomes of this project include mechanistic details of cell reprogramming, design rules for 3D prin ....Synthetic extracellular matrices for control of cellular reprogramming. This project aims to design materials that control the cellular environment for the fast, efficient, and reproducible production of reprogrammed cells in embryo-like architectures. Regenerative medicine has entered a new era, where reprogramming a patient’s cells is now possible for studying and treating disease. The expected outcomes of this project include mechanistic details of cell reprogramming, design rules for 3D printing of living cells and commercially viable reprogramming materials. The project expects to contribute fundamental knowledge in materials and biomedical sciences, while providing tools that will benefit commercial ventures in cell and tissue manufacturing.Read moreRead less
The Role Of Force-sensing Ion Channels In Melanoma Migration
Funder
National Health and Medical Research Council
Funding Amount
$553,848.00
Summary
Metastasis of melanoma cells away from the primary tumour site carries a very poor patient prognosis.This research aims to characterise a novel signalling pathway that can regulate the migration (movement) of melanoma cells. This signalling pathway depends on force-sensing platforms that can rapidly convert physical inputs from the environment into an electrical signal within the cell. We are working to understand how these force-sensors function.
The cells that produce and maintain our cartilage, known as chondrocytes, do so by sensing changes in the mechanical environment, but precisely how chondrocytes detect these changes is not known. We are investigating the role of ion channels that are opened in direct response to mechanical movements within the cartilage.This project plans to identify the specific molecules that are participating in this process and to determine if they are therapeutic targets for treatment of osteoarthritis
Chemical listening devices: Novel sensors targeting the clandestine manufacture and transport of illicit drugs and explosives. There can be no doubt that protecting Australia's borders from the dual threats of terrorism and illicit drugs is of paramount importance to continuation of our well-being and way of life. Our chemical sensors are simple hand-held or remote chemical listening sensors, which will have the ability to sense the presence of characteristic chemical vapours associated with exp ....Chemical listening devices: Novel sensors targeting the clandestine manufacture and transport of illicit drugs and explosives. There can be no doubt that protecting Australia's borders from the dual threats of terrorism and illicit drugs is of paramount importance to continuation of our well-being and way of life. Our chemical sensors are simple hand-held or remote chemical listening sensors, which will have the ability to sense the presence of characteristic chemical vapours associated with explosives and illicit drugs. The simplicity and low cost of the chemical listening allows for installation at key locations -e.g. transport hubs, shipping containers, airports etc as well as placement within clandestine drug laboratories.Read moreRead less
Transient Tissue ‘priming’ Via FAK Inhibition To Impair Pancreatic Cancer Progression And Improve Sensitivity To Gemcitabine/Abraxane
Funder
National Health and Medical Research Council
Funding Amount
$643,848.00
Summary
The success of cancer drugs is dependent on many factors including the properties of the tumour tissue. As a tumour grows it changes the tissue around it, and this affects response to treatment. Combining classical biology with engineering to generate 3D models that mimic tumours, along with cutting-edge imaging technology and mouse models, we will target FAK-controlled cancer cell pathways that sense tissue changes, together with already approved cancer drugs to improve patient outcome.
Single-cell Optical Window Imaging In CDK1-FRET Biosensor Mice To Assess Tissue Stiffness And Optimise Delivery And Therapeutic Response To Gemcitabine/Abraxane In Pancreatic Cancer.
Funder
National Health and Medical Research Council
Funding Amount
$676,979.00
Summary
Inefficient drug response in solid tumour tissue is commonly a limiting factor in the clinical effectiveness of cancer therapies. Using cutting-edge imaging technology and 3D models that mimic the disease, we have mapped areas of poor drug response within distinct regions of tumours. Here, we pinpoint and specifically target key factors limiting efficient drug targeting in order to improve the encouraging anti-cancer profile of the new drug combination Gemcitabine/Abraxane in pancreatic cancer.
Biosensor Imaging In Preclinical Pancreatic Cancer Targeting: Taking Cancer Targeting To New Dimensions.
Funder
National Health and Medical Research Council
Funding Amount
$640,210.00
Summary
Using cutting-edge imaging technology and 3D models that mimic cancer, we can map areas of poor drug response within distinct 'stages' or regions of tumours. Here, we pinpoint and specifically target key factors limiting efficient drug response in order to improve the encouraging anti-cancer profile of new or current drugs in pancreatic cancer.
Modelling TRPV4 Skeletal Disorders Using Human IPSCs
Funder
National Health and Medical Research Council
Funding Amount
$1,171,187.00
Summary
Inherited skeletal disorders are a significant disease burden. Many gene mutations have been defined but we only have limited understanding about how they cause the disease. We will use patient skin cells and new in vitro re-programing technology to induce them to form cartilage cells to produce “disease in a dish” models of human skeletal disorders. These models will allow us to answer questions about how specific mutations cause disease and identify potential therapies